This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In the IT space, for example, resellers or distributors sell a company’s software as a service (SAAS) products through a strategic business partnership, instead of the company’s own sales team doing the work.
A few years later, the need to develop hardware and software led her to Backstage Capital. Anticipating future possibilities, she says, she also wanted to use “technology with an opt-in to verify a customer’s identity to dispense a product that’s regulated, like alcohol, cannabis, tobacco or pharmaceuticals.”
Khan is the founder and CEO of Green Sands Equity , a boutique venture capital firm focused on investing in the technology, health care, space and frontier tech fields. There are “ideas and technologies that aren’t here today, but when they come, they could bring paradigm shifts with them,” she says. “We We say ‘data,’” Kahn notes. “We
Neurofeedback is a non-pharmaceutical approach to improving brain health, mood, and cognitive disorders. ” One reason figures like Fallahpour are so bullish about neurofeedback therapy is that it incorporates cutting-edge technology with a noninvasive platform. “I What is neurofeedback?
For example, they might say, “We’re a bank,” or “We make office furniture,” or “We’re in the pharmaceutical business.” In other words, Larry Page sees Google as a broad portfolio of science, technology, and Internet-related resources that can be leveraged into almost any meaningful new venture. This is quite understandable.
At Vertex Pharmaceuticals, a Bell Ringing ceremony is held to celebrate important milestones in the development of treatment of diseases. Consider communication barriers such as language differences or access to communications technology. We don’t have big, fancy, complicated words, or equations.
On May 30, 2023 , over 350 AI executives, researchers, and engineers issued an open letter , warning that the technology they are developing could become a societal risk comparable to pandemics and nuclear war. Or will it pose serious threats, disrupting industries, economies, and societies in ways we are unprepared to handle? Who’s right?
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content